Status:
COMPLETED
In Vivo Three-Dimensional Determination of Osteoarthritis Brace Effectiveness
Lead Sponsor:
The University of Tennessee, Knoxville
Collaborating Sponsors:
BREG, Inc
Conditions:
Osteoarthritis, Knee
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
In vivo knee kinematics will be assessed for 20 subjects that have been clinically diagnosed with substantial unicompartmental osteoarthritis (OA) by one of the surgeons of Colorado Joint Replacement;...
Detailed Description
In vivo knee kinematics will be assessed for 20 subjects that have been clinically diagnosed with substantial unicompartmental osteoarthritis (OA) by one of the surgeons of Colorado Joint Replacement;...
Eligibility Criteria
Inclusion
- Must be a patient of Colorado Joint Replacement.
- Must be diagnosed with marked unicompartimental degenerative joint space narrowing.
- Bilateral subjects may not be included in the subject population
Exclusion
- Pregnant, potentially pregnant or lactating females. To satisfy radiation protocol, each female subject will be asked if she is pregnant, or possibly could be pregnant. A pregnant person will not be allowed to participate in the study.
- Subjects who are unable to perform normal walking.
- Subjects who are unwilling to sign Informed Consent/ HIPAA documents.
- Does not speak English.
Key Trial Info
Start Date :
July 12 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 6 2020
Estimated Enrollment :
23 Patients enrolled
Trial Details
Trial ID
NCT04111276
Start Date
July 12 2019
End Date
November 6 2020
Last Update
October 12 2021
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
Colorado Joint Replacement
Denver, Colorado, United States, 80210
2
Porter Adventist Hospital
Denver, Colorado, United States, 80210
3
University of Tennessee
Knoxville, Tennessee, United States, 37996